# Kenvue Inc.: financial statements, quarterly

KVUE · NYSE · CIK 1944048 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Jan 3

Pages: [Overview](/companies/kvue.md) · [Financials](/companies/kvue/financials.md) · [Filings](/companies/kvue/filings.md) · [Insiders](/companies/kvue/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kvue/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,666](/filings/0001944048-24-000057.md) | [3,894](/filings/0001944048-25-000129.md) | [4,000](/filings/0001944048-25-000177.md) | [3,899](/filings/0001944048-25-000198.md) | [3,662 d](/filings/0001944048-26-000030.md) | [3,741](/filings/0001944048-26-000098.md) | [3,839](/filings/0001944048-26-000142.md) | [3,764](/filings/0001944048-26-000168.md) | [3,780 d](/filings/0001944048-26-000030.md) | [3,909](/filings/0001944048-26-000098.md) | [3,955](/filings/0001944048-26-000142.md) | [3,886](/filings/0001944048-26-000168.md) |
| Cost of revenue | $m | [1,623 d](/filings/0001944048-26-000030.md) | [1,652](/filings/0001944048-25-000129.md) | [1,635](/filings/0001944048-25-000177.md) | [1,617](/filings/0001944048-25-000198.md) | [1,592 d](/filings/0001944048-26-000030.md) | [1,573](/filings/0001944048-26-000098.md) | [1,578](/filings/0001944048-26-000142.md) | [1,538](/filings/0001944048-26-000168.md) | [1,643 d](/filings/0001944048-26-000030.md) | [1,607](/filings/0001944048-26-000098.md) | [1,654](/filings/0001944048-26-000142.md) | [1,572](/filings/0001944048-26-000168.md) |
| Gross profit | $m | [2,043](/filings/0001944048-24-000057.md) | [2,242](/filings/0001944048-25-000129.md) | [2,365](/filings/0001944048-25-000177.md) | [2,282](/filings/0001944048-25-000198.md) | [2,070 d](/filings/0001944048-26-000030.md) | [2,168](/filings/0001944048-26-000098.md) | [2,261](/filings/0001944048-26-000142.md) | [2,226](/filings/0001944048-26-000168.md) | [2,137 d](/filings/0001944048-26-000030.md) | [2,302](/filings/0001944048-26-000098.md) | [2,301](/filings/0001944048-26-000142.md) | [2,314](/filings/0001944048-26-000168.md) |
| Research and development | $m | [133 d](/filings/0001944048-26-000030.md) | [100](/filings/0001944048-25-000129.md) | [105](/filings/0001944048-25-000177.md) | [97.0](/filings/0001944048-25-000198.md) | [106 d](/filings/0001944048-26-000030.md) | [99.0](/filings/0001944048-26-000098.md) | [91.0](/filings/0001944048-26-000142.md) | [94.0](/filings/0001944048-26-000168.md) | [98.0 d](/filings/0001944048-26-000030.md) | [84.0](/filings/0001944048-26-000098.md) | [94.0](/filings/0001944048-26-000142.md) | [96.0](/filings/0001944048-26-000168.md) |
| Selling, general and administrative | $m | [1,586 d](/filings/0001944048-26-000030.md) | [1,573](/filings/0001944048-25-000129.md) | [1,641](/filings/0001944048-25-000177.md) | [1,590](/filings/0001944048-25-000198.md) | [1,525 d](/filings/0001944048-26-000030.md) | [1,537](/filings/0001944048-26-000098.md) | [1,504](/filings/0001944048-26-000142.md) | [1,512](/filings/0001944048-26-000168.md) | [1,535 d](/filings/0001944048-26-000030.md) | [1,453](/filings/0001944048-26-000098.md) | [1,537](/filings/0001944048-26-000142.md) | [1,569](/filings/0001944048-26-000168.md) |
| Operating income | $m | [460 d](/filings/0001944048-26-000030.md) | [550](/filings/0001944048-25-000129.md) | [154](/filings/0001944048-25-000177.md) | [654](/filings/0001944048-25-000198.md) | [483 d](/filings/0001944048-26-000030.md) | [558](/filings/0001944048-26-000098.md) | [692](/filings/0001944048-26-000142.md) | [629](/filings/0001944048-26-000168.md) | [535 d](/filings/0001944048-26-000030.md) | [767](/filings/0001944048-26-000098.md) | [699](/filings/0001944048-26-000142.md) | [706](/filings/0001944048-26-000168.md) |
| Interest expense | $m | [96.0 d](/filings/0001944048-24-000057.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [30.0](/filings/0001944048-24-000057.md) | [131](/filings/0001944048-25-000129.md) | [7.0](/filings/0001944048-25-000177.md) | [194](/filings/0001944048-25-000198.md) | [53.0 d](/filings/0001944048-26-000030.md) | [136](/filings/0001944048-26-000098.md) | [168](/filings/0001944048-26-000142.md) | [128](/filings/0001944048-26-000168.md) | [97.0 d](/filings/0001944048-26-000030.md) | [198](/filings/0001944048-26-000098.md) | [142](/filings/0001944048-26-000142.md) | [179](/filings/0001944048-26-000168.md) |
| Net income | $m | [327](/filings/0001944048-24-000057.md) | [296](/filings/0001944048-25-000129.md) | [58.0](/filings/0001944048-25-000177.md) | [383](/filings/0001944048-25-000198.md) | [293 d](/filings/0001944048-26-000030.md) | [322](/filings/0001944048-26-000098.md) | [420](/filings/0001944048-26-000142.md) | [398](/filings/0001944048-26-000168.md) | [330 d](/filings/0001944048-26-000030.md) | [474](/filings/0001944048-26-000098.md) | [456](/filings/0001944048-26-000142.md) | [430](/filings/0001944048-26-000168.md) |
| Diluted EPS | $ per share | [0.17](/filings/0001944048-24-000057.md) | [0.15](/filings/0001944048-25-000129.md) | [0.03](/filings/0001944048-25-000177.md) | [0.20](/filings/0001944048-25-000198.md) | not reported | [0.17](/filings/0001944048-26-000098.md) | [0.22](/filings/0001944048-26-000142.md) | [0.21](/filings/0001944048-26-000168.md) | not reported | [0.25](/filings/0001944048-26-000098.md) | [0.24](/filings/0001944048-26-000142.md) | [0.22](/filings/0001944048-26-000168.md) |
| Basic EPS | $ per share | [0.17](/filings/0001944048-24-000057.md) | [0.15](/filings/0001944048-25-000129.md) | [0.03](/filings/0001944048-25-000177.md) | [0.20](/filings/0001944048-25-000198.md) | not reported | [0.17](/filings/0001944048-26-000098.md) | [0.22](/filings/0001944048-26-000142.md) | [0.21](/filings/0001944048-26-000168.md) | not reported | [0.25](/filings/0001944048-26-000098.md) | [0.24](/filings/0001944048-26-000142.md) | [0.22](/filings/0001944048-26-000168.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.4](/filings/0001944048-25-000033.md) | [1.2](/filings/0001944048-24-000100.md) | [1.0](/filings/0001944048-24-000139.md) | [1.1](/filings/0001944048-24-000152.md) | [1.1](/filings/0001944048-26-000030.md) | [1.1](/filings/0001944048-25-000129.md) | [1.1](/filings/0001944048-25-000177.md) | [1.1](/filings/0001944048-25-000198.md) | [1.1](/filings/0001944048-26-000168.md) | [1.1](/filings/0001944048-26-000098.md) | [1.1](/filings/0001944048-26-000142.md) | [1.0](/filings/0001944048-26-000168.md) |
| Current assets | $bn | [6.1](/filings/0001944048-25-000033.md) | [6.1](/filings/0001944048-24-000100.md) | [5.9](/filings/0001944048-24-000139.md) | [5.9](/filings/0001944048-24-000152.md) | [5.5](/filings/0001944048-26-000030.md) | [5.7](/filings/0001944048-25-000129.md) | [5.9](/filings/0001944048-25-000177.md) | [6.0](/filings/0001944048-25-000198.md) | [5.7](/filings/0001944048-26-000168.md) | [5.8](/filings/0001944048-26-000098.md) | [5.9](/filings/0001944048-26-000142.md) | [5.9](/filings/0001944048-26-000168.md) |
| Total assets | $bn | [27.9](/filings/0001944048-25-000033.md) | [27.3](/filings/0001944048-24-000100.md) | [26.4](/filings/0001944048-24-000139.md) | [26.9](/filings/0001944048-24-000152.md) | [25.6](/filings/0001944048-26-000030.md) | [26.3](/filings/0001944048-25-000129.md) | [27.1](/filings/0001944048-25-000177.md) | [27.2](/filings/0001944048-25-000198.md) | [27.1](/filings/0001944048-26-000168.md) | [26.9](/filings/0001944048-26-000098.md) | [26.7](/filings/0001944048-26-000142.md) | [26.7](/filings/0001944048-26-000168.md) |
| Current liabilities | $bn | [5.5](/filings/0001944048-25-000033.md) | [6.2](/filings/0001944048-24-000100.md) | [5.9](/filings/0001944048-24-000139.md) | [5.9](/filings/0001944048-24-000152.md) | [5.7](/filings/0001944048-26-000030.md) | [6.7](/filings/0001944048-25-000129.md) | [6.0](/filings/0001944048-25-000177.md) | [6.2](/filings/0001944048-25-000198.md) | [5.9](/filings/0001944048-26-000168.md) | [5.9](/filings/0001944048-26-000098.md) | [5.9](/filings/0001944048-26-000142.md) | [6.2](/filings/0001944048-26-000168.md) |
| Total liabilities | $bn | [16.6](/filings/0001944048-25-000033.md) | [16.7](/filings/0001944048-24-000100.md) | [16.3](/filings/0001944048-24-000139.md) | [16.3](/filings/0001944048-24-000152.md) | [15.9](/filings/0001944048-26-000030.md) | [16.2](/filings/0001944048-25-000129.md) | [16.4](/filings/0001944048-25-000177.md) | [16.6](/filings/0001944048-25-000198.md) | [16.3](/filings/0001944048-26-000168.md) | [16.2](/filings/0001944048-26-000098.md) | [16.2](/filings/0001944048-26-000142.md) | [16.5](/filings/0001944048-26-000168.md) |
| Long-term debt | $bn | [7.7](/filings/0001944048-24-000057.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $bn | [0.0](/filings/0001944048-25-000033.md) | [0.8](/filings/0001944048-24-000100.md) | [0.8](/filings/0001944048-24-000139.md) | [0.8](/filings/0001944048-24-000152.md) | [0.8](/filings/0001944048-26-000030.md) | [0.7](/filings/0001944048-25-000129.md) | [0.7](/filings/0001944048-25-000177.md) | [0.8](/filings/0001944048-25-000198.md) | [0.8](/filings/0001944048-26-000168.md) | [0.0](/filings/0001944048-26-000098.md) | [0.0](/filings/0001944048-26-000142.md) | [0.0](/filings/0001944048-26-000168.md) |
| Short-term borrowings | $bn | [0.6](/filings/0001944048-25-000033.md) | [0.8](/filings/0001944048-24-000100.md) | [0.7](/filings/0001944048-24-000139.md) | [0.9](/filings/0001944048-24-000152.md) | [0.8](/filings/0001944048-26-000030.md) | [1.7](/filings/0001944048-25-000129.md) | [0.8](/filings/0001944048-25-000177.md) | [1.2](/filings/0001944048-25-000198.md) | [0.7](/filings/0001944048-26-000168.md) | [1.6](/filings/0001944048-26-000098.md) | [1.4](/filings/0001944048-26-000142.md) | [1.1](/filings/0001944048-26-000168.md) |
| Shareholders' equity | $bn | [11.2](/filings/0001944048-26-000030.md) | [10.6](/filings/0001944048-25-000177.md) | [10.2](/filings/0001944048-25-000198.md) | [10.6](/filings/0001944048-25-000198.md) | [9.7](/filings/0001944048-26-000168.md) | [10.1](/filings/0001944048-26-000142.md) | [10.7](/filings/0001944048-26-000168.md) | [10.6](/filings/0001944048-26-000168.md) | [10.8](/filings/0001944048-26-000168.md) | [10.6](/filings/0001944048-26-000142.md) | [10.6](/filings/0001944048-26-000168.md) | [10.2](/filings/0001944048-26-000168.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q4 FY2024 (2024-12-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q4 FY2025 (2025-12-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [950 d](/filings/0001944048-26-000030.md) | [287](/filings/0001944048-25-000129.md) | [440 d](/filings/0001944048-25-000177.md) | [249 d](/filings/0001944048-25-000198.md) | [793 d](/filings/0001944048-26-000030.md) | [428](/filings/0001944048-26-000098.md) | [621 d](/filings/0001944048-26-000142.md) | [294 d](/filings/0001944048-26-000168.md) | [854 d](/filings/0001944048-26-000030.md) | [489](/filings/0001944048-26-000098.md) | [688 d](/filings/0001944048-26-000142.md) | [700 d](/filings/0001944048-26-000168.md) |
| Capital expenditure | $m | [223 d](/filings/0001944048-26-000030.md) | [153](/filings/0001944048-25-000129.md) | [90.0 d](/filings/0001944048-25-000177.md) | [59.0 d](/filings/0001944048-25-000198.md) | [132 d](/filings/0001944048-26-000030.md) | [179](/filings/0001944048-26-000098.md) | [88.0 d](/filings/0001944048-26-000142.md) | [98.0 d](/filings/0001944048-26-000168.md) | [110 d](/filings/0001944048-26-000030.md) | [139](/filings/0001944048-26-000098.md) | [64.0 d](/filings/0001944048-26-000142.md) | [80.0 d](/filings/0001944048-26-000168.md) |
| Dividends paid | $m | [383 d](/filings/0001944048-26-000030.md) | [383](/filings/0001944048-25-000129.md) | [383 d](/filings/0001944048-25-000177.md) | [393 d](/filings/0001944048-25-000198.md) | [393 d](/filings/0001944048-26-000030.md) | [392](/filings/0001944048-26-000098.md) | [393 d](/filings/0001944048-26-000142.md) | [398 d](/filings/0001944048-26-000168.md) | [398 d](/filings/0001944048-26-000030.md) | [398](/filings/0001944048-26-000098.md) | [398 d](/filings/0001944048-26-000142.md) | [403 d](/filings/0001944048-26-000168.md) |
| Share repurchases | $m | [7.0 d](/filings/0001944048-26-000030.md) | [91.0](/filings/0001944048-25-000129.md) | [0.0 d](/filings/0001944048-25-000177.md) | [23.0 d](/filings/0001944048-25-000198.md) | [121 d](/filings/0001944048-26-000030.md) | [63.0](/filings/0001944048-26-000098.md) | [64.0 d](/filings/0001944048-26-000142.md) | [70.0 d](/filings/0001944048-26-000168.md) | [0.0 d](/filings/0001944048-26-000030.md) | [0.0](/filings/0001944048-26-000098.md) | [0.0 d](/filings/0001944048-26-000142.md) | [0.0 d](/filings/0001944048-26-000168.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-04-02) | Q2 FY2023 (2023-07-02) | Q3 FY2023 (2023-10-01) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-29) | Q1 FY2025 (2025-03-30) | Q2 FY2025 (2025-06-29) | Q3 FY2025 (2025-09-28) | Q1 FY2026 (2026-03-29) | Q2 FY2026 (2026-06-28) | Q3 FY2026 (2026-09-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [1,716](/filings/0001944048-24-000100.md) | [1,838](/filings/0001944048-24-000139.md) | [1,920](/filings/0001944048-24-000152.md) | [1,920](/filings/0001944048-25-000129.md) | [1,920](/filings/0001944048-25-000177.md) | [1,924](/filings/0001944048-25-000198.md) | [1,925](/filings/0001944048-26-000098.md) | [1,928](/filings/0001944048-26-000142.md) | [1,923](/filings/0001944048-26-000168.md) | [1,922](/filings/0001944048-26-000098.md) | [1,923](/filings/0001944048-26-000142.md) | [1,926](/filings/0001944048-26-000168.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,921,768,446 at 2026-10-26, from the cover of the [10-Q filed 2026-10-30](/filings/0001944048-26-000168.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 31, 2026, 02:42 ET. No prices; not investment advice.